Brief: Piramal Pharma Says Closure Of Us FDA Inspection At Piramal Pharma's Manufacturing Facility Located At Riverview, Usa
17/04/2024 15:34
April 17 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* CLOSURE OF US FDA INSPECTION AT PIRAMAL PHARMA'S
MANUFACTURING
FACILITY LOCATED AT RIVERVIEW, USA
* US FDA HAS ISSUED AN ESTABLISHMENT INSPECTION REPORT (EIR)
FOR
RIVERVIEW, USA FACILITY
Source text for Eikon: ID:nNSE3XfKYh
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington